Kaynakça
Van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, Leib SL, Mourvillier B, Ostergaard C, Pagliano P, Pfister HW, Read RC, Sipahi OR, Brouwer MC; ESCMID Study Group for Infections of the Brain (ESGIB). ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22(Suppl 3):37-62.
Helweg-Larsen J, Astradsson A, Richhall H, Erdal J, Laursen A, Brennum J. Pyogenic Brain Abscess, A 15 year Survey. BMC Infectious Diseases. 2012;12:332.
Alvis Miranda H, Castellar-Leones SM, Elzain MA, Moscote-Salazar LR. Brain Abscess: Current Management. J Neurosci Rural Pract. 2013;4(Suppl 1):67-81.
Shivappa SG, Kulkarni M, Manjula SR, Oral B. Granulicatella elegans Bacteremia & Meningitis in a Child without Neurosurgical Interventions. Journal of Dental and Medical Sciences. 2014;13:1-4.
Zenone T, Durand DV. Brain abscesses caused by Abiotrophia defectiva: complication of immunosuppressive therapy in a patient with connective-tissue disease. Scand J Infect Dis. 2004;36:497-9.
Procop GW, Church DL, Hall GS, Janda WM, Koneman EW. The Anaerobic Bacteria. Koneman"s Color Atlas and Textbook of Diagnostic Microbiology, 7th ed. Philadelphia: Wolters Kluwer; 2017:983-1073.
Klein M, Pfister HW, Tunkel AR. Brain abscess. In: Scheld WM, Whitley RJ, Marra CM, editors. Infections of the Central Nervous System. 4th ed. Philadelphia: Lippincott Williams & Wilkins. 2014;p.550.
Alberti MO, Hindler JA, Humphries RM. Antimicrobial Susceptibilities of Abiotrophia defectiva, Granulicatella adiacens, and Granulicatella elegans. Antimicrob Agents Chemother. 2016;60:1411-20.
Prasidthrathsint K, Fisher MA. Antimicrobial Susceptibility Patterns among a Large, Nationwide Cohort of Abiotrophia and Granulicatella Clinical Isolates. J Clin Microbiol. 2017;55:1025-31.
